Enter your login e-mail to the account
Search
- Management of anemia in patients with Myelodysplastic Syndrome
MUDr. Eva Mikušková, MUDr. Tomáš Guman, PhD., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár
(3-4/2014, Interdisciplinary consilium ) - Antiinfektíva (registrované k 29. 6. 2004)
MUDr. Eva Mikušková
(11/2005, Memorix ) - Antihypertenzíva registrované v SR k 29. 6. 2004.
MUDr. Eva Mikušková
(3/2004, Memorix )
- Extracorporeal photophoresis in treatment of Graft vs Host disease
MUDr. Radka Vašíčková, MUDr. Eva Mikušková, PhD., MBA, MUDr. Iveta Oravcová, PhD.
(6/2025, Main topic ) - Twenty years of treatment of acute promyelocytic leukemia in National Cancer Institute
MUDr. Iveta Oravcová, PhD., MUDr. Eva Mikušková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Vanda Mikudová, MUDr. Silvia Cingelová, PhD., MUDr. Alica Slobodová, MUDr. Jana Jankechová, MUDr. Radka Vašíčková, MUDr. Kristína Bandurová, MUDr. Denis Urban, doc. MUDr. Ľuboš Drgoňa, CSc.
(5/2022, Original articles ) - Acute myeloblastic leukemia in Slovakia and the presence of the FLT3 mutation
MUDr. Eva Mikušková, PhD.
(2/2021, Original articles ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - Febrile neutropenia – view on antimicrobial stewardship in oncohaematology
doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Andrej Vranovský, PhD., MUDr. Eva Mikušková, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Miriam Ladická
(5/2020, Review articles ) - Selected epidemiological aspects of chronic lymphocytic leukaemia in Slovakia: results from the cross-sectional study
MUDr. Eva Mikušková, PhD., MUDr. Elena Marušáková, MBA, doc. MUDr. Ľuboš Drgoňa, CSc., MUDr. Emília Flochová, PhD., MUDr. Tomáš Guman, PhD., Prof. MUDr. Mikuláš Hrubiško, CSc., MUDr. Juraj Chudej, PhD., MUDr. Jana Jurkovičová, Prof. MUDr. Eva Králíková, CSc., MUDr. Miroslav Šimek, PhD., MUDr. Natália Štecová, MVDr. Martina Vulganová
(1/2020, Original articles ) - Diagnosis and prognostic score in a patient with myelodysplastic syndrome
MUDr. Eva Mikušková, PhD., MUDr. Stanislava Fliegová PhD., MUDr. Juraj Chudej, PhD.
(5/2018, Main topic ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Decision making about the treatment of older patients with acute myeloblastic leukemia – case reports
MUDr. Iveta Oravcová, PhD., MUDr. Eva Mikušková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Vanda Mikudová, MUDr. Silvia Cingelová, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(1/2018, Original articles & case reports ) - The current status of biological therapy for relapsed/refractory classical hodgkin lymphoma – a case report
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Original articles & case reports ) - Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Myelodysplastic syndrome – medicine made to measure
MUDr. Eva Mikušková, doc. MUDr. Ján Staško, PhD., MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(6/2014, Spectrum ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Additional chromosomal abnormalities in patients with acute promyelocytic leukemia – their impact on outcome
MUDr. Eva Mikušková, MUDr. Iveta Oravcová, MUDr. Pavol Kotouček, MUDr. Radoslav Greksák, MUDr. Ľudmila Demitrovičová, MUDr. Eva Demečková, MUDr. Branislav Czako
(6/2009, Original articles & case reports ) - CHRONIC LYMPHOCYTIC LEUKEMIA – STAGING AND TREATMENT (PART 2)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(6/2008, Review articles ) - CHRONIC LYMPHOCYTIC LEUKEMIA – BIOLOGY, PROGNOSIS AND CLINICAL PICTURES (PART 1)
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová
(5/2008, Review articles ) - CHRONIC MYELOID LEUKEMIA – NEW TRENDS IN THE TREATMENT
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(5/2008, Review articles ) - TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE KHAT AND NOU IN BRATISLAVA – OUR EXPERIENCES
MUDr. Eva Mikušková, doc. MUDr. Martin Mistrík, PhD., MUDr. Iveta Oravcová, MUDr. Pavol Kotouček, MUDr. Radoslav Greksák
(6/2007, Original articles )













